Cart
sales@molnova.com
Lanraplenib
CAS No. 1800046-95-0
Lanraplenib( GS-9876 )
Catalog No. M23810 CAS No. 1800046-95-0
Lanraplenib is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 111 | In Stock |
|
| 2MG | 65 | In Stock |
|
| 5MG | 96 | In Stock |
|
| 10MG | 162 | In Stock |
|
| 25MG | 291 | In Stock |
|
| 50MG | 421 | In Stock |
|
| 100MG | 620 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLanraplenib
-
NoteResearch use only, not for human use.
-
Brief DescriptionLanraplenib is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases.
-
DescriptionLanraplenib is a highly selective and orally active SYK inhibitor (IC50=9.5 nM) in development for the treatment of inflammatory diseases. Lanraplenib inhibits SYK activity in platelets via the glycoprotein VI (GPVI) receptor without prolonging bleeding time (BT) in monkeys or humans.
-
In Vitro——
-
In Vivo——
-
SynonymsGS-9876
-
PathwayAngiogenesis
-
TargetSyk
-
RecptorSYK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1800046-95-0
-
Formula Weight443.5
-
Molecular FormulaC23H25N9O
-
Purity>98% (HPLC)
-
SolubilityDMSO:41.67 mg/mL (93.96 mM; Need ultrasonic)
-
SMILESC1CN(CCN1C2COC2)C3=CC=C(C=C3)NC4=NC(=CN5C4=NC=C5)C6=CN=CC(=N6)N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Di Paolo J, et al. FRI0049 Preclinical Characterization of GS-9876, A Novel, Oral SYK Inhibitor That Shows Efficacy in Multiple Established Rat Models of Collagen-Induced Arthritis.Annals of the Rheumatic Diseases 2016;75:443-444.
molnova catalog
related products
-
MNS
MNS is a tyrosine kinases inhibitor inhibits Syk Src p97 with IC50 of 2.5 μM 29.3 μM and 1.7 μM respectively.
-
Fostamatinib
Fostamatinib (R788 disodium salt) is a prodrug of the active metabolite R406, which is a potent, ATP-competitive inhibitor of Syk kinase with Ki/IC50 of 30/41 nM.
-
TC-S 7003
TC-S 7003 (Lck Inhibitor) is an orally active, selective and potent lymphocyte kinase (Lck) inhibitor with anti-inflammatory activity, inhibition of Lck, Lyn, Src, and Syk kinases, and inhibition of T-cell proliferation, and may be useful in the study of arthritis.
